[Sponsored] With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. The post The Top-Rated Suppliers of Lu-177 for Cancer Research appeared first on MedCity News.
Cybersecurity is no longer a function managed in the IT department’s back office. It’s a front-line brand issue, with real implications for patient satisfaction and loyalty. That means providers need to rethink how they talk about security. It’s no longer enough to be secure; you must communicate security clearly. The post Why Cybersecurity Is Now…
EVERSANA is merging with Waltz Health under the EVERSANA name. Mark Thierer, co-founder and CEO of Waltz Health, will serve as the CEO of the combined company. The post EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company appeared first on MedCity News.
Zemcelpro, a cord blood-sourced cell therapy developed by startup ExCellThera, received conditional marketing authorization in Europe as a treatment for blood cancer patients who can’t find a matched donor. It’s the first cell therapy approved in Europe for this group of patients. The post European Commission Approval Gives Blood Cancer Patients a New Cell Therapy…
Susan Monarez has left her role as CDC director after less than a month — the shortest tenure in the agency’s history — following reported clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine policy. This news comes amid a period of turmoil at the CDC, including a recent deadly shooting at its headquarters….
Moving clinical data management to cloud platforms can carry myriad benefits for healthcare organizations. The post Bringing Clinical Data Management to the Cloud appeared first on MedCity News.
The path to a sustainable HaH program looks different for regional systems. A smaller, more focused program, designed around their unique needs, can deliver strong clinical and operational value. The post How Can Hospital-at-Home Grow Outside the Nation’s Biggest Health Systems? appeared first on MedCity News.
[Sponsored] Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people. The post The Role of RWD in Revolutionizing Clinical Trial Design appeared first on MedCity News.
Pluto Health launched an AI-driven digital hub that unifies fragmented health data, provides personalized care navigation and integrates clinical research opportunities to help close primary care access gaps. The platform aims to improve care coordination and make research participation more accessible, especially for patients without insurance or a regular primary care provider. The post Duke…
Cemdisiran, a small interfering RNA drug that Regeneron Pharmaceuticals licensed from Alnylam Pharmaceuticals, met the goals of its pivotal test in generalized myasthenia gravis. The rare neuromuscular disease has several new therapies, but analysts see cemdisiran as having advantages over one particular class of drugs. The post Regeneron’s RNA Med for Muscle Disease Meets Trial…